Effect of rifaximin on enterogenous endotoxemia and liver inflammation in patients with chronic active hepatitis or compensated cirrhosis

HE Yun; ZHAO Cui-ping; LI Hong; LI Zheng; ZHAO Qing-xia; FAN Man-qi

doi:10.3969/j.issn.1007-8134.2012.04.009

Home>Articles>Effect of rifaximin on enterogenous endotoxemia and liver inflammation in patients with chronic active hepatitis or compensated cirrhosis

DOI: 10.3969/j.issn.1007-8134.2012.04.009

Effect of rifaximin on enterogenous endotoxemia and liver inflammation in patients with chronic active hepatitis or compensated cirrhosis

HE Yun

ZHAO Cui-ping

LI Hong

LI Zheng

ZHAO Qing-xia

FAN Man-qi

Machine-generated Keywords：

Publication Date：2012-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 220-222 )

INFECTIOUS DISEASE INFORMATION

ISTIC

ISSN：1007-8134

Year, Vol.(Issue)：2012,25(4)